Analyst Andres Y. Maldonado of H.C. Wainwright reiterated a Buy rating on Mural Oncology Plc (MURA – Research Report), retaining the ...
Arch Resources downgraded at Jefferies, citing balanced risk/reward after Trump rally and key operational risks post-merger.
At this point, while I do not think that the product will have no end market, I do question whether the commercial success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback